STOCK TITAN

Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Bio-Rad Laboratories, Inc. (NYSE: BIO) will announce its third-quarter 2020 financial results on October 29, 2020, after the market closes. A conference call is scheduled for 3 PM PT (6 PM ET) to discuss these results. The call can be accessed by dialing 855-779-9068 for U.S. callers or 631-485-4862 for international callers, using passcode 7061137. Additionally, interested parties can listen to the live webcast on the Investor Relations section of the company's website.

Positive
  • Scheduled discussion of third-quarter results may indicate transparency and engagement with investors.
  • Potential for positive market response depending on the financial performance.
Negative
  • None.

HERCULES, Calif.--()--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the third quarter 2020 on Thursday, October 29, 2020, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.

To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the U.S., passcode: 7061137. You may also listen to the conference call live via a webcast that is available on the “Investor Relations” section of our website under “Quarterly Results” at bio-rad.com. The webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.3 billion in 2019. For more information, please visit bio-rad.com.

Contacts

Investor Contact:
Kevin Han, Senior Director
Investor Relations
510-741-6777
ir@bio-rad.com

Media Contact:
Tina Cuccia, Manager
Corporate Communications
510-741-6063
tina_cuccia@bio-rad.com

FAQ

What are the third-quarter 2020 earnings expectations for Bio-Rad (BIO)?

The earnings expectations for Bio-Rad will be discussed in the scheduled conference call on October 29, 2020.

When will Bio-Rad report its financial results for Q3 2020?

Bio-Rad will report its financial results for the third quarter on October 29, 2020.

How can I listen to Bio-Rad's Q3 2020 earnings call?

You can listen to the earnings call by calling 855-779-9068 (U.S.) or 631-485-4862 (international) or via the webcast on their Investor Relations website.

What is the importance of the upcoming conference call for Bio-Rad (BIO)?

The conference call on October 29, 2020, is important as it provides insights into Bio-Rad's financial performance and outlook.

Bio-Rad Laboratories, Inc.

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Stock Data

9.25B
19.42M
15.58%
78.32%
2.33%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
HERCULES